Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Short term Debt (2019 - 2026)

Viatris (VTRS) posted Short term Debt of $1.7 billion for Q2 2026, down 9.95% on a QoQ basis from $1.9 billion in Q1 2026, and up 3.46% year-over-year from $1.7 billion in Q2 2025.

Analysis

Viatris (VTRS) Short term Debt (2019 - 2026) Analysis & Trends

Viatris has reported Short term Debt for 8 years, with the latest figure at $1.7 billion in Q2 2026.

  • On a quarterly basis, Short term Debt rose 3.46% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 3.46% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 23192.77% from the prior year.
  • Short term Debt was $1.7 billion for Q2 2026 at Viatris, down from $1.9 billion in the prior quarter.
  • The five-year high for Short term Debt was $2.6 billion in Q1 2022, with the low at $8.3 million in Q4 2024.
  • Average Short term Debt over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Short term Debt slumped 99.57% in 2024, then jumped 23192.77% in 2025.
  • Over 5 years, Short term Debt stood at $1.3 billion in 2022, then surged by 54.35% to $1.9 billion in 2023, then plunged by 99.57% to $8.3 million in 2024, then surged by 23192.77% to $1.9 billion in 2025, then retreated by 10.06% to $1.7 billion in 2026.
  • The last three Short term Debt figures came in at $1.7 billion (Q2 2026), $1.9 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Bn
Mar 31, 2026 1.93 Bn
Dec 31, 2025 1.93 Bn
Sep 30, 2025 1.95 Bn
Jun 30, 2025 1.68 Bn
Mar 31, 2025 8.50 Mn
Dec 31, 2024 8.30 Mn
Sep 30, 2024 1.45 Bn
Jun 30, 2024 2.37 Bn
Mar 31, 2024 1.90 Bn
Dec 31, 2023 1.94 Bn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 1.33 Bn
Mar 31, 2023 508.70 Mn
Dec 31, 2022 1.26 Bn
Sep 30, 2022 763.80 Mn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 2.61 Bn
Dec 31, 2021 1.88 Bn
Sep 30, 2021 1.91 Bn